Background: Dysphagia as a main manifestation of extrapyramidal symptoms is an uncommon adverse effect of second-generation antipsychotics.
Method: We present a 54-year-old drug-naïve patient with schizophrenia, who developed dysphagia with aripiprazole 30 mg daily treatment.
Results: This is the first case report on aripiprazole-induced dysphagia. We discuss the risk factors that led to dysphagia in this case.
Conclusion: Aripiprazole-induced dysphagia is rare, and it is important to be aware that it does occur with high-dosage treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/eat.20934 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!